Functional variability of the adenosine A3 receptor (ADORA3) gene polymorphism in aspirin-induced urticaria

British Journal of Dermatology

Volumn 163, Issue 5, 2010, Pages 977-985

  Kim, S H ^a   Nam, E J ^a   Kim, Y K ^b   Ye, Y M ^a   Park, H S ^a  

^a Ajou University School of Medicine   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Adenosine; Adenosine A3 receptor; Aspirin hypersensitivity; Genetic polymorphism; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE A2 RECEPTOR; ADENOSINE A3 RECEPTOR; DNA BINDING PROTEIN; HISTAMINE; LUCIFERASE; MESSENGER RNA;

ADULT; AGED; ALLELE; ARTICLE; ASPIRIN INDUCED URTICARIA; BASOPHIL; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME ASSAY; EX VIVO STUDY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HAPLOTYPE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; KOREA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; URTICARIA;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASIAN CONTINENTAL ANCESTRY GROUP; ASPIRIN; BASOPHILS; CASE-CONTROL STUDIES; DRUG HYPERSENSITIVITY; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HISTAMINE; HUMANS; KOREA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTOR, ADENOSINE A2B; RECEPTOR, ADENOSINE A3; URTICARIA;

EID: 78249275559     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09983.x     Document Type: Article

References (37)

1. Grattan CE,. Aspirin sensitivity and urticaria. Clin Exp Dermatol 2003; 28: 123 -7.
2. Simon RA,. Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs. Curr Allergy Asthma Rep 2004; 4: 17 -24.
3. Szczeklik A,. The cyclooxygenase theory of aspirin-induced asthma. Eur Respir J 1990; 3: 588 -93.
4. Ye YM, Kim JE, Kim SH, et al. Clinical characteristics of chronic urticaria with aspirin sensitivity. J Asthma Allergy Clin Immunol 2005; 25: 194 -9.
5. Kim SH, Park HS,. Pathogenesis of nonsteroidal antiinflammatory drug-induced asthma. Curr Opin Allergy Clin Immunol 2006; 6: 17 -22.
6. Bae JS, Kim SH, Ye YM, et al. Significant association of FcepsilonRIalpha promoter polymorphisms with aspirin-intolerant chronic urticaria. J Allergy Clin Immunol 2007; 119: 449 -56.
7. Kim SH, Kang YM, Kim SH, et al. Histamine N-methyltransferase 939A/G polymorphism affects mRNA stability in patients with acetylsalicylic acid-intolerant chronic urticaria. Allergy 2009; 64: 213 -21.
8. Kim SH, Choi JH, Holloway JW, et al. Leukotriene-related gene polymorphisms in patients with aspirin-intolerant urticaria and aspirin-intolerant asthma: differing contributions of ALOX5 polymorphism in Korean population. J Korean Med Sci 2005; 20: 926 -31.
9. Kim SH, Choi JH, Park HS, et al. Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma. Clin Exp Allergy 2005; 35: 585 -90.
10. Kim SH, Oh JM, Kim YS, et al. Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males. Clin Exp Allergy 2006; 36: 433 -9.
11. Kopp E, Ghosh S,. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994; 265: 956 -9.
12. Paul-Clark MJ, Van Cao T, Moradi-Bidhendi N, et al. 15-Epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation. J Exp Med 2004; 200: 69 -78.
13. Perretti M, Chiang N, La M, et al. Endogenous lipid-and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med 2002; 8: 1296 -302.
14. Kopff A, Kopff M, Kowalczyk E,. The influence of nonsteroidal anti-inflammatory drugs on deaminase adenosine activity. Pol Arch Med Wewn 2006; 116: 832 -7.
15. Ajloo D, Saboury AA, Haghi-Asli N, et al. Kinetic, thermodynamic and statistical studies on the inhibition of adenosine deaminase by aspirin and diclofenac. J Enzyme Inhib Med Chem 2007; 22: 395 -406.
16. Mingatto FE, Santos AC, Uyemura SA, et al. In vitro interaction of nonsteroidal anti-inflammatory drugs on oxidative phosphorylation of rat kidney mitochondria: respiration and ATP synthesis. Arch Biochem Biophys 1996; 334: 303 -8.
17. Mann JS, Holgate ST, Renwick AG, Cushley MJ,. Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol 1986; 61: 1667 -76.
18. Walker BA, Jacobson MA, Knight DA, et al. Adenosine A3 receptor expression and function in eosinophils. Am J Respir Cell Mol Biol 1997; 16: 531 -7.
19. Johnson HG, McNee ML,. Adenosine-induced secretion in the canine trachea: modification by methylxanthines and adenosine derivatives. Br J Pharmacol 1985; 86: 63 -7.
20. Peachell PT, Lichtenstein LM, Schleimer RP,. Differential regulation of human basophil and lung mast cell function by adenosine. J Pharmacol Exp Ther 1991; 256: 717 -26.
21. Forsythe P, Ennis M,. Adenosine, mast cells and asthma. Inflamm Res 1999; 48: 301 -7.
22. Tilley SL, Wagoner VA, Salvatore CA, et al. Adenosine and inosine increase cutaneous vasopermeability by activating A3 receptors on mast cells. J Clin Invest 2000; 105: 361 -7.
23. Olah ME, Stiles GL,. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu Rev Pharmacol Toxicol 1995; 35: 581 -606.
24. Feoktistov I, Biaggioni I,. Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. J Clin Invest 1995; 96: 1979 -86.
25. Ramkumar V, Stiles GL, Beaven MA, Ali H,. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 1993; 268: 16887 -90.
26. Fozard JR, Pfannkuche HJ, Schuurman HJ,. Mast cell degranulation following adenosine A3 receptor activation in rats. Eur J Pharmacol 1996; 298: 293 -7.
27. Reeves JJ, Jones CA, Sheehan MJ, et al. Adenosine A3 receptors promote degranulation of rat mast cells both in vitro and in vivo. Inflamm Res 1997; 46: 180 -4.
28. Kim SH, Choi JH, Lee KW, et al. The human leucocyte antigen-DRB1 1302-DQB1 0609-DPB1 0201 haplotype may be a strong genetic marker for aspirin-induced urticaria. Clin Exp Allergy 2005; 35: 339 -44.
29. Hedrick PW,. Gametic disequilibrium measures: proceed with caution. Genetics 1987; 117: 331 -41.
30. Kim SH, Kim YK, Park HW, et al. Adenosine deaminase and adenosine receptor polymorphisms in aspirin-intolerant asthma. Respir Med 2009; 103: 356 -63.
31. Barrett JC, Fry B, Maller J, Daly MJ,. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263 -5.
32. Mukherjee S, Lekli I, Das M, et al. Cardioprotection with alpha-tocopheryl phosphate: amelioration of myocardial ischemia reperfusion injury is linked with its ability to generate a survival signal through Akt activation. Biochim Biophys Acta 2008; 1782: 498 -503.
33. Madi L, Cohen S, Ochayin A, et al. Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kappaB in mediating receptor level. J Rheumatol 2007; 34: 20 -6.
34. Marquardt DL, Parker CW, Sullivan TJ,. Potentiation of mast cell mediator release by adenosine. J Immunol 1978; 120: 871 -8.
35. Marquardt DL, Walker LL, Heinemann SF,. Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells. J Immunol 1994; 150: 4508 -15.
36. Auchampach JA, Jin X, Wan TC, et al. Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2b receptor. Mol Pharmacol 1997; 52: 846 -60.
37. Zhong H, Shlykov SG, Molina JG, et al. Activation of murine lung mast cells by the adenosine A3 receptor. J Immunol 2003; 171: 338 -45.